Skip to main content
Clinical Trials/JPRN-UMIN000013491
JPRN-UMIN000013491
Recruiting
Phase 2

Prospective Cohort Study Evaluating the Prognosis of Patients with Resectable Large 3 and 4 Type Gastric Cancer and Clinical Phase II trial Evaluating the Safety and Benefit of Perioperative Chemotherapy for Resectable Large 3 and 4 Type Gastric Cancer - CoBLa trial

Department of Surgical Oncology, Kanazawa Medical University0 sites40 target enrollmentMarch 24, 2014
Conditionsgastric cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
gastric cancer
Sponsor
Department of Surgical Oncology, Kanazawa Medical University
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 24, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Surgical Oncology, Kanazawa Medical University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. administration contraindication of TS\-1, CDDP, DOC, PAC 2\. severe complications such as paralytic ileus, bowel obstruction, interstitial pneumonitis or pulmonary fibrosis, uncontrolled diabetes mellitus, heart failure, renal failure and hepatic failure etc. 3\. massive ascites or pleural effusion 4\. severe watery diarrhea 5\. schronous double cancer 6\. pregnancy or lactation 7\. physician concludes that the patient's participation in this trial is inappropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials